{
  "hypothesis": "h268",
  "status": "inconclusive",
  "reason": "Existing h163 data does not split autoimmune by subtype",
  "existing_findings": {
    "nsaid_autoimmune": "50% (HIGH tier)",
    "dmard_autoimmune": "75.4% (GOLDEN tier via h157)",
    "corticosteroid_autoimmune": "46.1%",
    "kinase_inhibitor_autoimmune": "30.8%",
    "receptor_fusion_autoimmune": "30.0%"
  },
  "recommendation": "Would need dedicated subtype evaluation to determine optimal drug class per subtype"
}